, Tracking Stock Market Picks
Enter Symbol:
Keryx Biopharmaceuticals, Inc. (KERX) [hlAlert]

Mkt Outperform
up 43.18 %

Keryx Biopharmaceuticals, Inc. (KERX) rated Mkt Outperform with price target $8 by JMP Securities

Posted on: Wednesday,  Mar 16, 2011  10:25 AM ET by JMP Securities

JMP Securities rated Mkt Outperform Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) on 03/16/2011, when the stock price was $4.33.
Since then, Keryx Biopharmaceuticals, Inc. has gained 43.19% as of 01/12/2016's recent price of $6.20.
If you would have followed this JMP Securities's recommendation on KERX, you would have gained 43.18% of your investment in 1763 days.

Keryx Biophamaceutical, Inc. uses data discovered through the mapping of the human genome to generate drug candidates that target the regulation of protein kinases. Protein kinases play a key role in the way cells communicate.

MP Securities' equity research department provides institutional clients with comprehensive industry knowledge, unique insight and actionable information. JMP's senior research analysts are charged with developing proprietary investment themes, anticipating secular and cyclical changes and producing action-oriented reports. JMP follows companies in six industries that exhibit above-average long-term growth characteristics — Technology, Healthcare, Consumer, Real Estate, Financial Services and Business Services — and produces specialized equity research that enables investors to understand and invest in complicated growth stocks profitably.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/16/2011 10:25 AM Buy
4.33 8.00
as of 12/30/2011
1 Week up  2.01 %
1 Month down  -4.16 %
3 Months down  -15.66 %
1 YTD down  -41.57 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy